EnteroBiotix

Bellshill, United Kingdom · Founded 2017 · Privately Held (backing)

Developer of microbiome-modulating drugs designed to restore health and prevent bacterial infections. EnteroBiotix is based in Bellshill, United Kingdom and was founded in 2017. Its last reported valuation was $66.8 million in Mar 2024. It has raised $94.2 million across 6 recorded rounds; the latest was a $5.3 million early-stage round in Mar 2026.

Last reported valuation
$66.8M
Oct 2026
Priced at
—
Total raised
$94.2M
Last round
Early Stage VC
Mar 2026
What is EnteroBiotix worth?
$66.8Mlast reported valuation · Oct 2026

EnteroBiotix's last reported valuation, Mar 2024. Nothing priced has surfaced since.

Free account
More of EnteroBiotix with a free account
  • ·The complete investor list: 20 names
  • ·Watch EnteroBiotix: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

EnteroBiotix funding history

6 rounds
DateRoundRaisedPost-money
Mar 2026Early Stage VC$5.3M▮
Jul 2025Seed Round$1.4M▮
Mar 2024Seed Round$1.3M▮
Jan 2024Seed Round$2.6M▮
Aug 2023Early Stage VC$6.7M▮
Aug 2022Early Stage VC$11.2M▮
Unlock post-money valuations

Membership and data by Private Market View

EnteroBiotix valuation

EnteroBiotix's last reported valuation was $66.8 million in Mar 2024. No priced round, secondary trade or fund mark has surfaced since.

How much has EnteroBiotix raised?

EnteroBiotix has raised $94.2 million in total; 6 of its rounds are on record, from 2022 on. The largest on record was a $6.7 million early-stage round in Aug 2023; the most recent was a $5.3 million early-stage round in Mar 2026.

EnteroBiotix has filed 5 Form Ds with the SEC since 2022, most recently in Jul 2025 ($1.4 million sold to 2 investors).

How EnteroBiotix's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For EnteroBiotix, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about EnteroBiotix

What is EnteroBiotix worth?
EnteroBiotix is valued at $66.8M as of Oct 2026. EnteroBiotix's last reported valuation, Mar 2024. Nothing priced has surfaced since.
How much has EnteroBiotix raised?
EnteroBiotix has raised $94.2M in total funding across 6 recorded rounds.
When did EnteroBiotix last raise?
EnteroBiotix last raised in Mar 2026 (Early Stage VC), raising $5.3M.